After 17 years of research, India’s homegrown dengue vaccine reaches final trials

After 17 years of analysis, India’s first indigenous
dengue vaccine, DengiAll, is capturing international consideration because it reaches the ultimate levels of improvement. The Section‑III human trials of the vaccine, developed by Delhi‑primarily based Panacea Biotec with assist from the Indian Council of Medical Analysis (ICMR), at the moment are full or near completion throughout a number of websites within the nation.

Dr Syed Khalid Ali, Chief Scientific Officer at Panacea Biotec, says DengiAll comes at a vital time. “DengiAll has been within the making for over 15 years, and it comes at a time when half the world’s inhabitants is vulnerable to dengue,” he advised The Print.

An extended street to a brand new hope

The Section‑III trial, which started enrolling members in August 2024, has concerned greater than 10,000 volunteers at almost 20 websites throughout India. Individuals are being adopted intently to see how nicely the vaccine works towards dengue, which may vary from gentle flu‑like sickness to life‑threatening problems.

DengiAll is designed to guard towards all 4 dengue virus serotypes in a single shot. It’s a notable achievement, given how complicated dengue’s 4 distinct strains are to deal with in a single vaccine. In earlier Section‑I and Section‑II trials, the vaccine confirmed safety ranges between 77–82 per cent towards all 4 serotypes.

What comes subsequent

Now comes the essential half: convincing regulators of the vaccine’s security and effectiveness.

If the interim evaluation from the Section‑III trial, which can be potential as soon as sufficient confirmed dengue instances happen amongst members, is constructive, Panacea Biotec might start searching for approval even earlier than the complete two‑yr observe‑up interval ends.

“At a time when dengue instances and deaths mount yearly, every single day we delay, we’re denying them their life,” Khalid advised The Print.

If authorised, DengiAll might rework dengue prevention not simply in India however in different tropical areas the place the illness is a significant public well being menace.